These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8356062)

  • 21. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.
    Zaleska A; Eiwegger T; Soyer O; van de Veen W; Rhyner C; Soyka MB; Bekpen C; Demiröz D; Treis A; Söllner S; Palomares O; Kwok WW; Rose H; Senti G; Kündig TM; Ozoren N; Jutel M; Akdis CA; Crameri R; Akdis M
    Allergy; 2014 Sep; 69(9):1162-70. PubMed ID: 24934402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design of hypoallergens applied to the major cat allergen Fel d 1.
    Saarne T; Kaiser L; Grönlund H; Rasool O; Gafvelin G; van Hage-Hamsten M
    Clin Exp Allergy; 2005 May; 35(5):657-63. PubMed ID: 15898990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response modulation by recombinant peptides expressed in virus-like particles.
    Svirshchevskaya EV; Alekseeva L; Marchenko A; Viskova N; Andronova TM; Benevolenskii SV; Kurup VP
    Clin Exp Immunol; 2002 Feb; 127(2):199-205. PubMed ID: 11876740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
    Alexander C; Tarzi M; Larché M; Kay AB
    Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.
    Thoms F; Jennings GT; Maudrich M; Vogel M; Haas S; Zeltins A; Hofmann-Lehmann R; Riond B; Grossmann J; Hunziker P; Fettelschoss-Gabriel A; Senti G; Kündig TM; Bachmann MF
    J Allergy Clin Immunol; 2019 Jul; 144(1):193-203. PubMed ID: 31056187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.
    Alexander C; Ying S; B Kay A; Larché M
    Clin Exp Allergy; 2005 Jan; 35(1):52-8. PubMed ID: 15649266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial.
    Oldfield WL; Larché M; Kay AB
    Lancet; 2002 Jul; 360(9326):47-53. PubMed ID: 12114041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgE and IgG binding patterns and T-cell recognition of Fel d 1 and non-Fel d 1 cat allergens.
    Hales BJ; Chai LY; Hazell L; Elliot CE; Stone S; O'Neil SE; Smith WA; Thomas WR
    J Allergy Clin Immunol Pract; 2013; 1(6):656-65.e1-5. PubMed ID: 24565714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intralymphatic injections as a new administration route for allergen-specific immunotherapy.
    Martínez-Gómez JM; Johansen P; Erdmann I; Senti G; Crameri R; Kündig TM
    Int Arch Allergy Immunol; 2009; 150(1):59-65. PubMed ID: 19339803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.
    Rudulier CD; Tonti E; James E; Kwok WW; Larché M
    Allergy; 2019 Nov; 74(11):2157-2166. PubMed ID: 31077596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of major cat allergen Fel d 1 mimotopes on filamentous phage carriers.
    Luzar J; Molek P; Šilar M; Korošec P; Košnik M; Štrukelj B; Lunder M
    Mol Immunol; 2016 Mar; 71():176-183. PubMed ID: 26908079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4.
    Vandebriel RJ; De Jong WH; Spiekstra SW; Van Dijk M; Fluitman A; Garssen J; Van Loveren H
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):77-85. PubMed ID: 10637130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen.
    Marazuela EG; Rodríguez R; Fernández-García H; García MS; Villalba M; Batanero E
    Mol Immunol; 2008 Jan; 45(2):438-45. PubMed ID: 17662454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen.
    Terada T; Zhang K; Belperio J; Londhe V; Saxon A
    Clin Immunol; 2006 Jul; 120(1):45-56. PubMed ID: 16473552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapeutic potential of the immunodominant T-cell epitope of lipocalin allergen Bos d 2 and its analogues.
    Saarelainen SA; Kinnunen TT; Buhot C; Närvänen AT; Kauppinen AK; Rytkönen-Nissinen MA; Maillere B; Virtanen TI
    Immunology; 2008 Mar; 123(3):358-66. PubMed ID: 17944901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cat allergen-induced cytokine secretion and Fel d 1-immunoglobulin G immune complexes in cord blood.
    Casas R; Jenmalm MC; Björkstén B
    Clin Exp Allergy; 2004 Apr; 34(4):591-6. PubMed ID: 15080812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cat allergy with T-cell reactive peptides.
    Norman PS; Ohman JL; Long AA; Creticos PS; Gefter MA; Shaked Z; Wood RA; Eggleston PA; Hafner KB; Rao P; Lichtenstein LM; Jones NH; Nicodemus CF
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1623-8. PubMed ID: 8970345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice.
    Thunberg S; Neimert-Andersson T; Cheng Q; Wermeling F; Bergström U; Swedin L; Dahlén SE; Arnér E; Scheynius A; Karlsson MC; Gafvelin G; van Hage M; Grönlund H
    Allergy; 2009 Jun; 64(6):919-26. PubMed ID: 19183417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell epitope-specific defects in the immune response to cat allergen in patients with atopic dermatitis.
    Carneiro R; Reefer A; Wilson B; Hammer J; Platts-Mills T; Custis N; Woodfolk J
    J Invest Dermatol; 2004 Apr; 122(4):927-36. PubMed ID: 15102083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.